FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616661736> ?p ?o ?g. }

• W2616661736 endingPage "1538" @default.
• W2616661736 startingPage "1532" @default.
• W2616661736 abstract "Atopic dermatitis (AD) is a skin disorder characterized by filaggrin (FLG) defect. We evaluated sacran’s effects on dust-mite extracts (DME)-induced AD-like disease and also its effect on profilaggrin (proFLG) in a murine model of 2,4-dinitroflurobenze (DNFB)-induced contact hypersensitivity. In the murine AD-like disease model, allergic NC/Nga mice (N = 60) were randomly divided into five treatment groups of 12 animals each: 0.2% and 1%sacran; 0.1% Tacrolimus; Vaseline and buffer-treated controls. Blood samples were drawn and serum levels of representative Th-1, Th-2 and also Th-17 (IL-17A) cytokines were assayed by Cytometric Bead Array (CBA). In the contact hypersensitivity model, diseased NC/Nga mice (N = 20) were divided into four groups of five mice each [0.05%sacran, 0.05% chondroitin sulfate (CS), 0.5% prednisolone (PD), non-treated control group] and were treated for 14 days. Skin biopsies were performed for the measurement of proFLG-mRNA by real-time PCR. Sacran solutions and 0.1%Tacrolimus reduced disease severity, suppressed histological changes and decreased the serum Th-1 (IFN-γ, TNF-α, IL-2) and Th-2 (IL-4, IL-6, IL-10) cytokines in allergic mice (vs. controls). Additionally, a marked increase of proFLG-mRNA expression was observed in 0.05%sacran group (vs. control 0.05% CS and 0.5% PD groups). Thus, Sacran might be useful as a natural skin barrier enhancer and anti-allergic agent." @default.
• W2616661736 created "2017-05-26" @default.
• W2616661736 creator A5013014848 @default.
• W2616661736 creator A5018227254 @default.
• W2616661736 creator A5030049169 @default.
• W2616661736 creator A5042697150 @default.
• W2616661736 creator A5045011154 @default.
• W2616661736 creator A5054769661 @default.
• W2616661736 creator A5056086946 @default.
• W2616661736 creator A5068587459 @default.
• W2616661736 creator A5074553150 @default.
• W2616661736 creator A5085602637 @default.
• W2616661736 creator A5086855818 @default.
• W2616661736 date "2017-12-01" @default.
• W2616661736 modified "2023-10-18" @default.
• W2616661736 title "Anti-allergic and Profilaggrin (ProFLG)-mRNA expression modulatory effects of sacran" @default.
• W2616661736 cites W1915788507 @default.
• W2616661736 cites W1967292242 @default.
• W2616661736 cites W1982670399 @default.
• W2616661736 cites W198427113 @default.
• W2616661736 cites W1999690368 @default.
• W2616661736 cites W2002607190 @default.
• W2616661736 cites W2018976775 @default.
• W2616661736 cites W2023850807 @default.
• W2616661736 cites W2028590815 @default.
• W2616661736 cites W2048629459 @default.
• W2616661736 cites W2057098942 @default.
• W2616661736 cites W2060879765 @default.
• W2616661736 cites W2062718629 @default.
• W2616661736 cites W2075857386 @default.
• W2616661736 cites W2079001947 @default.
• W2616661736 cites W2081361312 @default.
• W2616661736 cites W2085258093 @default.
• W2616661736 cites W2103986874 @default.
• W2616661736 cites W2129016936 @default.
• W2616661736 cites W2144120552 @default.
• W2616661736 cites W2162201817 @default.
• W2616661736 cites W2162666912 @default.
• W2616661736 cites W2165277651 @default.
• W2616661736 cites W2346486327 @default.
• W2616661736 cites W2529642587 @default.
• W2616661736 cites W3188708564 @default.
• W2616661736 cites W4230355606 @default.
• W2616661736 doi "https://doi.org/10.1016/j.ijbiomac.2017.05.049" @default.
• W2616661736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28522399" @default.
• W2616661736 hasPublicationYear "2017" @default.
• W2616661736 type Work @default.
• W2616661736 sameAs 2616661736 @default.
• W2616661736 citedByCount "10" @default.
• W2616661736 countsByYear W26166617362017 @default.
• W2616661736 countsByYear W26166617362018 @default.
• W2616661736 countsByYear W26166617362021 @default.
• W2616661736 countsByYear W26166617362022 @default.
• W2616661736 countsByYear W26166617362023 @default.
• W2616661736 crossrefType "journal-article" @default.
• W2616661736 hasAuthorship W2616661736A5013014848 @default.
• W2616661736 hasAuthorship W2616661736A5018227254 @default.
• W2616661736 hasAuthorship W2616661736A5030049169 @default.
• W2616661736 hasAuthorship W2616661736A5042697150 @default.
• W2616661736 hasAuthorship W2616661736A5045011154 @default.
• W2616661736 hasAuthorship W2616661736A5054769661 @default.
• W2616661736 hasAuthorship W2616661736A5056086946 @default.
• W2616661736 hasAuthorship W2616661736A5068587459 @default.
• W2616661736 hasAuthorship W2616661736A5074553150 @default.
• W2616661736 hasAuthorship W2616661736A5085602637 @default.
• W2616661736 hasAuthorship W2616661736A5086855818 @default.
• W2616661736 hasConcept C13373296 @default.
• W2616661736 hasConcept C185592680 @default.
• W2616661736 hasConcept C190684412 @default.
• W2616661736 hasConcept C203014093 @default.
• W2616661736 hasConcept C207480886 @default.
• W2616661736 hasConcept C2776056826 @default.
• W2616661736 hasConcept C2777716647 @default.
• W2616661736 hasConcept C2778329239 @default.
• W2616661736 hasConcept C2780269544 @default.
• W2616661736 hasConcept C31849713 @default.
• W2616661736 hasConcept C71924100 @default.
• W2616661736 hasConcept C8891405 @default.
• W2616661736 hasConceptScore W2616661736C13373296 @default.
• W2616661736 hasConceptScore W2616661736C185592680 @default.
• W2616661736 hasConceptScore W2616661736C190684412 @default.
• W2616661736 hasConceptScore W2616661736C203014093 @default.
• W2616661736 hasConceptScore W2616661736C207480886 @default.
• W2616661736 hasConceptScore W2616661736C2776056826 @default.
• W2616661736 hasConceptScore W2616661736C2777716647 @default.
• W2616661736 hasConceptScore W2616661736C2778329239 @default.
• W2616661736 hasConceptScore W2616661736C2780269544 @default.
• W2616661736 hasConceptScore W2616661736C31849713 @default.
• W2616661736 hasConceptScore W2616661736C71924100 @default.
• W2616661736 hasConceptScore W2616661736C8891405 @default.
• W2616661736 hasFunder F4320321680 @default.
• W2616661736 hasLocation W26166617361 @default.
• W2616661736 hasLocation W26166617362 @default.
• W2616661736 hasOpenAccess W2616661736 @default.
• W2616661736 hasPrimaryLocation W26166617361 @default.
• W2616661736 hasRelatedWork W1167372180 @default.
• W2616661736 hasRelatedWork W2081533686 @default.
• W2616661736 hasRelatedWork W2104449005 @default.

• next